Reduced CYP7A1 may result in a buildup of intracellular cholesterol, leading to toxic effects such as altered membrane integrity; reduced CYP7A1 is associated with greater severity of NASH (56). The gene discussed is CYP7A1; the disease is metabolic dysfunction-associated steatohepatitis.